Healthcare
Live Price
Offline$3.35
+6.01% today
1Y Change
+0.76%
Window
Jun 23, 2025 → Jun 9, 2026
Coverage: 242 bars · Jun 23, 2025 → Jun 9, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Rocket Pharmaceuticals, Inc. (RCKT) is a Healthcare stock with a market cap of $390.00M and listed on NASDAQ. The stock last traded around $3.35 and up 0.8% across the available one-year price window (Jun 23, 2025 → Jun 9, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +26.4%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +26.4%, free cash flow +11.7% with operating margin 0.0% and ROIC -76.4%. Stock Foundry combines RCKT price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
RCKT
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
RCKT Max Drawdown
-50.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for RCKT and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.